Micro-costing in health and medicine: a critical appraisal.
Micro-costing in health and medicine: a critical appraisal.
复制标题
DOI：
10.1186/s13561-020-00298-5
复制
发表时间：
2021-01-06
影响因子：
2.4
通讯作者：
Ruger JP
中科院分区：
文献类型：
--
作者：
Xu X;Lazar CM;Ruger JP
对医疗保健成本上升的担忧需要进行严格的经济研究，以便为临床和政策决策提供信息。微观成本计算是一种成本估算方法，采用详细的资源利用和单位成本数据，对经济成本进行精确估算。微观成本计算研究尚未得到严格评价。用英语对微观成本研究进行批判性评价。通过经济评价准则（Evers、Drummond、综合卫生经济评价报告标准（CHEERS）、Fukuda和Imanaka清单），对完全或主要采用微成本计算的研究进行了方法和报告质量评价。根据保健和医药成本效益小组的定义，微成本计算研究涉及“直接查点和计算治疗特定病人所消耗的每一种投入的成本”。全部或主要的微成本研究包括肿瘤（18.5%）、传染病和寄生虫病（17.9%）以及循环系统疾病（10.8%），这些是研究最多的疾病。36.9%在美国，34.9%在欧洲。33.8%没有报告分析视角，32.8%没有报告价格年份，3.6%没有通货膨胀调整成本数据，44.1%没有说明通货膨胀调整。86.2%没有单独报告单位成本和资源利用量，14.9%和19.5%没有提供足够的细节来评估计量的实物单位或价值成本的适当性。微额成本计算研究在方法和报告质量方面差别很大，这突出表明需要使微额成本计算研究的方法和报告标准化，并开发评价工具。在线版本包含补充材料，可通过10.1186/s13561-020-00298-5获得。
Concerns about rising health care costs require rigorous economic study to inform clinical and policy decision-making. Micro-costing is a cost estimation methodology employing detailed resource utilization and unit cost data to generate precise estimates of economic costs. Micro-costing studies have not been critically appraised. Critical appraisal of micro-costing studies in English. Studies fully or predominantly employing micro-costing were appraised for methodological and reporting quality through economic evaluation guidelines (Evers, Drummond, Consolidated Health Economic Evaluation Reporting Standards (CHEERS), Fukuda and Imanaka checklists). Following the Panel on Cost Effectiveness in Health and Medicine, micro-costing studies were defined as involving “direct enumeration and costing out of every input consumed in the treatment of a particular patient.” Full or predominant micro-costing studies included neoplasms (18.5%), infectious and parasitic diseases (17.9%), and diseases of circulatory systems (10.8%) as the most studied diseases. 36.9% were in the United States and 34.9% were in Europe. 33.8% did not report analytic perspective, 32.8% did not report price year, 3.6% did not inflation adjust cost data, and 44.1% did not specify inflation adjustment. 86.2% did not separately report unit costs and resource utilization quantity, 14.9 and 19.5% did not provide sufficient detail to assess appropriateness of measured physical units or valued costs. Micro-costing studies vary widely in methodological and reporting quality, highlighting the need to standardize methods and reporting of micro-costing studies and develop tools for their evaluation. The online version contains supplementary material available at 10.1186/s13561-020-00298-5.
登录
查看更多内容
影响因子：
3
作者：
Frick, Kevin D.
通讯作者：
Frick, Kevin D.
影响因子：
3.7
作者：
Mercier, Gregoire;Naro, Gerald
通讯作者：
Naro, Gerald
影响因子：
4.4
作者：
Olsson, Tina M.
通讯作者：
Olsson, Tina M.
DOI：
10.1007/s10198-004-0259-9
发表时间：
2005-03-01
期刊：
The European journal of health economics : HEPAC : health economics in prevention and care
影响因子：
--
作者：
Wordsworth, Sarah;Ludbrook, Anne;Macleod, Alison
通讯作者：
Macleod, Alison
影响因子：
4.5
作者：
Husereau, Don;Drummond, Michael;Loder, Elizabeth
通讯作者：
Loder, Elizabeth